Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cardiotoxicity × Amplified Fragment Length Polymorphism Analysis × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 21 Lymphoma 12 Leukemia 12 Lymphoma, Follicular 11 Lymphoma, Large B-Cell, Diffuse 9 Rectal Neoplasms 8 Prostatic Neoplasms 8 Colonic Neoplasms 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Lymphoma, Non-Hodgkin 7 Lymphoma, B-Cell, Marginal Zone 7 Lung Neoplasms 7 Leukemia, Lymphocytic, Chronic, B-Cell 7 Hodgkin Disease 7 Colorectal Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Ovarian Neoplasms 6 Multiple Myeloma 6 Lymphoma, Mantle-Cell 6 Lymphoma, Large-Cell, Immunoblastic 6 Congenital Abnormalities 6 Carcinoma, Ovarian Epithelial 6 Burkitt Lymphoma 6 Neuroblastoma 5 Lymphoma, T-Cell, Cutaneous 5 Leukemia, Myeloid, Acute 5 Central Nervous System Neoplasms 5 Sezary Syndrome 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Myeloproliferative Disorders 4

Interventions

Doxorubicin 15 Echocardiography 13 Exercise 8 Electrocardiography 7 Dexrazoxane 7 Cyclophosphamide 7 Trastuzumab 6 Razoxane 5 Carvedilol 5 Vincristine 4 Filgrastim 4 Radiotherapy 3 Methotrexate 3 Granulocyte Colony-Stimulating Factor 3 Etoposide 3 Docetaxel 3 Cisplatin 3 Atorvastatin 3 salicylhydroxamic acid 2 sacubitril and valsartan sodium hydrate drug combination 2 empagliflozin 2 Tablets 2 Social Determinants of Health 2 Prednisone 2 Magnetic Resonance Spectroscopy 2 Leucovorin 2 Ivabradine 2 High-Intensity Interval Training 2 Chemotherapy, Adjuvant 2 Blood Specimen Collection 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00875238 2018-02-19

PACE in BC

Vanderbilt University Medical Center

Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡